Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.510
-0.110 (-2.38%)
Aug 31, 2026, 2:20 PM EDT - Market open

Whitehawk Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
--7.1514.3821.627.7825.9825.0723.8223.8424.3523.2621.5418.7815.2210.996.743.311.1214.27
Revenue Growth (YoY)
---72.50%-42.63%-9.32%16.51%6.69%7.80%10.57%26.97%60.05%111.62%219.41%467.76%1258.57%-22.99%-53.49%-77.33%-92.32%-
Cost of Revenue
--0.76-20.79-24.33-10.463.0252.6154.454.551.7447.6444.4138.513431.6328.022319.6717.77
Gross Profit
--6.3935.1745.9338.2422.96-27.54-30.58-30.66-27.38-24.38-22.87-19.73-18.78-20.64-21.28-19.69-18.55-3.5
Selling, General & Admin
22.5723.329.8235.0136.9938.9436.7536.0440.0843.9644.5545.3144.0142.2440.1838.7936.2727.118.519.21
Research & Development
63.4999.4190.96108.63108.6359.8251.03-------------
Operating Expenses
86.06122.7120.79143.63145.6298.7687.7836.0440.0843.9644.5545.3144.0142.2440.1838.7936.2727.118.519.21
Operating Income
-86.06-122.7-114.4-108.46-99.69-60.53-64.82-63.59-70.66-74.62-71.93-69.69-66.88-61.97-58.96-59.43-57.55-46.79-37.06-12.71
Interest Expense
-----0.04-0.1-0.15-0.21-0.23-0.23-0.23-0.23-0.23-0.23-0.23-0.23-0.33-0.5-0.67-0.84
Interest & Investment Income
6.266.776.235.34.353.433.934.755.456.026.46.515.524.042.40.80.180.030.010
Currency Exchange Gain (Loss)
00.010.01-0-0-0-0-0-0-0-0-0-0-------
Other Non Operating Income (Expenses)
0.140.30.30.290.16---------------
EBT Excluding Unusual Items
-79.65-115.63-107.86-102.88-95.22-57.19-61.05-59.05-65.44-68.83-65.77-63.42-61.59-58.16-56.79-58.86-57.69-47.26-37.71-13.55
Merger & Restructuring Charges
-----2.64-2.64-2.64-2.64------------
Gain (Loss) on Sale of Assets
-0.18-0.1887.2787.2787.4487.44--------------
Asset Writedown
--------------3.72-3.72-3.72-77.88-74.16-74.16-74.16
Other Unusual Items
----------------0.382.951.781.63
Pretax Income
-79.83-115.81-20.6-15.62-10.4227.61-63.69-61.69-65.44-68.83-65.77-63.42-61.59-61.88-60.51-62.58-135.2-118.47-110.09-86.08
Income Tax Expense
------------0.01-0.01--0.010.01000
Net Income
-79.83-115.81-20.6-15.62-10.4227.61-63.69-61.69-65.44-68.83-65.77-63.41-61.58-61.88-60.51-62.59-135.2-118.47-110.09-86.08
Preferred Dividends & Other Adjustments
----------------0.650.650.650.89
Net Income to Common
-79.83-115.81-20.6-15.62-10.4227.61-63.69-61.69-65.44-68.83-65.77-63.41-61.58-61.88-60.51-62.59-135.85-119.12-110.74-86.97
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
73696251413027272727272725242321181494
Shares Outstanding (Diluted)
73696251413027272727272725242321181494
Shares Change (YoY)
78.42%128.91%128.96%89.98%51.07%12.32%0.42%0.38%5.88%12.29%19.58%27.81%40.59%77.55%152.27%389.02%126.12%1051.13%250.99%-
EPS (Basic)
-1.10-1.67-0.33-0.30-0.260.91-2.36-2.28-2.43-2.55-2.44-2.36-2.42-2.58-2.69-2.97-7.50-8.81-12.41-20.21
EPS (Diluted)
-1.10-1.67-0.33-0.31-0.260.91-2.36-2.28-2.43-2.56-2.44-2.36-2.42-2.58-2.69-2.97-7.50-8.81-12.41-20.21
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-69.35-107.78-97.99-95.99-96.49-53.23-61.2-56.43-53.6-61.35-63.64-64.56-59.81-53.33-50.08-51.17-60.25-52.47-22.47-13.27
Free Cash Flow Per Share
-0.95-1.56-1.58-1.87-2.37-1.76-2.26-2.09-1.99-2.28-2.36-2.40-2.35-2.22-2.23-2.43-3.32-3.88-2.52-3.08
Gross Margin
--89.36%244.52%212.67%137.66%88.36%-109.86%-128.40%-128.60%-112.44%-104.84%-106.18%-105.10%-123.43%-187.85%----24.52%
Operating Margin
---1601.12%-754.05%-461.62%-217.91%-249.47%-253.63%-296.68%-313.00%-295.36%-299.68%-310.47%-330.04%-387.47%-540.81%-853.32%-1414.82%-3309.02%-89.09%
Profit Margin
---288.26%-108.58%-48.24%99.42%-245.13%-246.06%-274.77%-288.72%-270.04%-272.67%-285.88%-329.56%-397.69%-569.57%-2014.40%-3602.00%-9887.23%-609.53%
Free Cash Flow Margin
---1371.38%-667.34%-446.78%-191.64%-235.55%-225.07%-225.04%-257.33%-261.29%-277.63%-277.66%-284.01%-329.15%-465.65%-893.33%-1586.63%-2006.16%-93.00%
EBITDA
-86.06-122.68-114.32-108.34-99.52-60.33-64.63-63.4-70.47-74.44-71.76-69.52-66.74-61.85-58.8-59.25-57.35-46.61-36.96-12.68
EBITDA Margin
------217.19%-248.73%-252.87%-295.89%--294.67%-298.95%--------88.84%
D&A For EBITDA
0.010.020.080.130.170.20.190.190.190.180.170.170.140.120.160.190.20.180.110.04
EBIT
-86.06-122.7-114.4-108.46-99.69-60.53-64.82-63.59-70.66-74.62-71.93-69.69-66.88-61.97-58.96-59.43-57.55-46.79-37.06-12.71
EBIT Margin
------217.91%-249.47%-253.63%-296.68%--295.36%-299.68%--------89.09%
Revenue as Reported
--7.1514.3821.627.7825.9825.0723.8223.8424.3523.2621.5418.7815.2210.996.743.311.1214.27
SEC Filings: 10-K · 10-Q